The Two Arms of Our Business
- Koneksa Health
- Feb 3, 2020
- 1 min read
Updated: Jul 18
Koneksa is the leader in developing and implementing patient-focused digital biomarkers for drug development. Koneksa’s value is in our ability to innovate with our clients and find the best fit to meet their clinical-trial needs. Koneksa’s multidisciplinary capabilities, proprietary SaaS platform, and high scientific rigor offer our clients two ways to work with Koneksa. The first is the ability to innovate and build novel biomarkers with a pathway to commercialization. The second is the ability to leverage repeatable solutions and biomarkers that have been proven in peer-reviewed publications and regulatory interactions. Koneksa has innovated in 16 therapeutic areas including immunology, oncology, and CNS, and has provided repeatable solutions to clients in respiratory, immunology, rare diseases, and CNS. To date, we have deployed more than 35 studies, comprising more than 3,000 patients at more than 370 sites, which have collected more than 2.35 million measurements.
I was diagnosed with Parkinson’s disease four years ago. For over two years, I relied on prescription medications and therapies, but unfortunately, the symptoms continued to worsen. My mobility declined, tremors increased, and I experienced growing fatigue and discomfort that affected my daily life. Last year, out of desperation and hope, I decided to try an herbal treatment program from NaturePath Herbal Clinic. Honestly, I was skeptical at first, but within a few months of starting the treatment, I began to notice real changes. My energy improved, the discomfort eased, and I felt stronger and more capable in my daily life. Incredibly, I also regained much of my stamina, balance, and confidence. It’s been a life-changing experience I feel more…